KeyCorp restated their buy rating on shares of Invacare (NYSE:IVC) in a report issued on Thursday, December 21st. KeyCorp currently has a $20.00 target price on the health services provider’s stock.
Separately, Zacks Investment Research upgraded shares of Invacare from a sell rating to a hold rating in a report on Wednesday, October 11th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The stock has a consensus rating of Hold and a consensus target price of $16.00.
Invacare (NYSE:IVC) opened at $17.05 on Thursday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.57 and a current ratio of 2.28. Invacare has a one year low of $9.90 and a one year high of $17.95. The company has a market cap of $658.34, a P/E ratio of -7.26 and a beta of 2.45.
Invacare (NYSE:IVC) last issued its earnings results on Tuesday, November 7th. The health services provider reported ($0.41) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.02. Invacare had a negative net margin of 7.95% and a negative return on equity of 13.33%. The company had revenue of $250.91 million for the quarter, compared to the consensus estimate of $239.88 million. During the same period in the previous year, the firm earned ($0.37) earnings per share. The firm’s revenue for the quarter was down 6.4% on a year-over-year basis. sell-side analysts predict that Invacare will post -2.12 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Thursday, January 4th will be issued a dividend of $0.0125 per share. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Wednesday, January 3rd. Invacare’s dividend payout ratio (DPR) is presently -2.13%.
Several hedge funds have recently made changes to their positions in the company. Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in shares of Invacare by 654.1% during the 3rd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 2,383,222 shares of the health services provider’s stock valued at $37,535,000 after buying an additional 2,067,186 shares in the last quarter. Perceptive Advisors LLC purchased a new position in shares of Invacare in the 3rd quarter worth about $3,950,000. Harvey Partners LLC raised its position in shares of Invacare by 860.6% in the 3rd quarter. Harvey Partners LLC now owns 126,800 shares of the health services provider’s stock worth $1,997,000 after purchasing an additional 113,600 shares during the last quarter. Keeley Teton Advisors LLC raised its position in shares of Invacare by 1,779.1% in the 3rd quarter. Keeley Teton Advisors LLC now owns 442,715 shares of the health services provider’s stock worth $6,973,000 after purchasing an additional 419,155 shares during the last quarter. Finally, Royce & Associates LP raised its position in shares of Invacare by 4.4% in the 3rd quarter. Royce & Associates LP now owns 1,414,169 shares of the health services provider’s stock worth $22,273,000 after purchasing an additional 59,430 shares during the last quarter. Hedge funds and other institutional investors own 94.65% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/14/invacares-ivc-buy-rating-reaffirmed-at-keycorp.html.
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.